Turning novel discoveries into innovative healthcare solutions
Kane Biotech Inc. is a research and discovery based, growing biotechnology company with expertise in creating products that prevent and disperse bacterial biofilms.
Biofilms develop when bacteria and other microorganisms form a protective environment that acts as a shield against attack. When in a biofilm, bacteria become highly resistant to antibiotics, high temperatures and host immune responses. This resiliency contributes to human health problems such as recurrent urinary tract infections, medical device related infections and tooth decay.
News
July 22 , 2008
Kane Biotech Enters Into a Material Transfer and Evaluation Agreement with Ward Industries Group
> Read more
July 7 , 2008
Key Milestone Met in DispersinB™ Manufacturing Process
> Read more
July 2 , 2008
A New Study Shows DispersinB™ Helps our Body's Immune Cells to Kill Bacteria
> Read more
June 25 , 2008
Kane Biotech Receives Notice of Allowance for DispersinB™ as a Registered Trademark
> Read more
Novel approaches to controlling bacterial pathogens
With an understanding of the important role that biofilms play in both the survival and the dominance of bacteria, Kane Biotech believes that solutions to the biofilm problem will play an increasing role in combating infectious diseases. The cost and consequence of infectious diseases continues to increase worldwide, and the opportunity for Kane Biotech to develop unique products that have a positive impact on human health is clear. We are strongly committed to advancing our research and the development of our growing pipeline of products for commercialization.
Kane Biotech has one of the leading collections of biofilm related technologies, positioning us at the forefront of this rapidly developing and vastly underserved field. Our products are designed to make significant contributions to human health problems such as hospital-acquired medical device related infections and tooth decay.
